Results 1 to 10 of about 13,067 (212)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy

open access: diamondRevista da Sociedade Brasileira de Medicina Tropical, 2021
INTRODUCTION: The minute ventilation-carbon dioxide production relationship (VE/VCO2 slope) is among the main prognostic factors of Chagas cardiomyopathy whose determinants remain unknown. METHODS: Seventy-eight patients with Chagas cardiomyopathy were
Lucas Frois Fernandes Oliveira   +9 more
doaj   +2 more sources

Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy

open access: goldJournal of Veterinary Internal Medicine, 2022
Chagas cardiomyopathy, caused by the protozoal parasite Trypanosoma cruzi, is characterized by arrhythmias, myocardial damage, heart failure, and sudden death.
Elizabeth L. Malcolm   +4 more
doaj   +2 more sources

Circulating microRNAs as biomarkers of Chagas cardiomyopathy [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundChagas cardiomyopathy (CHCM) is the most important clinical manifestation of Chagas disease. The analysis of cardiac miRNAs may contribute to predicting the progression to CHCM in Chagas indeterminate phase and/or to the differential diagnosis ...
Laura Antonietti   +13 more
doaj   +2 more sources

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study [PDF]

open access: goldNutrition Journal, 2017
Background Several studies have been focusing on the effect of omega-3 polyunsaturated fatty acids on modulation of inflammatory markers in several cardiopathies.
Paula Simplício da Silva   +10 more
doaj   +2 more sources

Chagas Disease Cardiomyopathy: Immunopathology and Genetics [PDF]

open access: goldMediators of Inflammation, 2014
Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop chronic Chagas disease cardiomyopathy (CCC), a particularly lethal ...
Edecio Cunha-Neto, Christophe Chevillard
doaj   +2 more sources

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy. [PDF]

open access: goldPLoS Neglected Tropical Diseases, 2018
Chagas cardiomyopathy is a serious and common complication of Chagas disease.Through bibliometric and Social Network Analysis, we examined patterns of research on Chagas cardiomyopathy, identifying the main countries, authors, research clusters, and ...
Gregorio González-Alcaide   +2 more
doaj   +3 more sources

Echocardiographic predictors of mortality in heart failure from Chagas cardiomyopathy: Refining risk stratification with speckle-tracking echocardiography [PDF]

open access: yesAmerican Heart Journal Plus
Background: Chagas cardiomyopathy is a major cause of mortality in endemic regions, predicted primarily by left ventricular (LV) systolic function. Speckle-tracking echocardiography (STE)–derived strain is a sensitive tool for assessing ventricular ...
Marcelo Alves Maia   +10 more
doaj   +2 more sources

A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: A pilot single-arm clinical trial

open access: goldJournal of Research in Medical Sciences, 2020
Background: Cardiac rehabilitation exerts anti-inflammatory effect on several cardiovascular diseases; however, these effects were not described for Chagas cardiomyopathy, which is associated with pro-inflammatory imbalance.
Luiz Fernando Rodrigues Junior   +7 more
doaj   +2 more sources

Stroke in Chagas disease: from pathophysiology to clinical practice [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2022
Despite substantial progress toward its control, Chagas disease continues to be a major public health problem in Latin America and has become a global health concern.
Thaís Aparecida Reis Lage   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy